Playback speed
10 seconds
ASH 2022: Zanubrutinib in Acalabrutinib-Intolerant Patients With B-Cell Malignancies
By
ASH 2022 Conference Coverage
FEATURING
Mazyar Shadman
By
ASH 2022 Conference Coverage
FEATURING
Mazyar Shadman
136 views
December 19, 2022
Login to view comments.
Click here to Login